Muheebur Rehman | Health Professions | Excellence in Research

Posted on by ScienceFather

Dr. Muheebur Rehman | Health Professions | Excellence in Research

Assistant Professor at Abasyn university Peshawar, Pakistan

Dr. Muheebur Rehman is an Assistant Professor at Abasyn University Peshawar, Pakistan, specializing in applied and industrial physical therapy, rehabilitation medicine, sports science, biomechanics, and kinesiology. With a strong background in clinical physiotherapy, he integrates academic and practical knowledge to foster research in rehabilitation, particularly in cardiopulmonary and musculoskeletal conditions. Known for his goal-oriented and analytical approach, Dr. Rehman is committed to advancing medical research in physical therapy, offering a wealth of experience in both academic teaching and clinical practice. His multifaceted career includes extensive volunteer work, active participation in conferences, and contributions to scientific journals, highlighting his dedication to the growth of his field.

Professional Profile

Education:

Dr. Rehman holds a Master of Science in Cardiopulmonary Physical Therapy from Riphah International University, Islamabad (2019-2021), where he conducted innovative research on the effects of exercise training in lung cancer patients undergoing chemotherapy. Prior to that, he earned a Doctor of Physical Therapy (DPT) degree from Bacha Khan University, Charsadda (2013-2018), with research on non-specific cervical pain in adults. His academic journey reflects his deep commitment to improving rehabilitation strategies, combining advanced academic training with a focus on practical, evidence-based solutions in physical therapy and rehabilitation.

Professional Experience:

Dr. Muheebur Rehman has significant experience in both clinical and academic settings. Since 2020, he has served as an Assistant Professor and Clinical Instructor at Abasyn University Peshawar, where he lectures on rehabilitation medicine and physical therapy. His career includes a range of clinical roles, such as Clinical Physiotherapist at Hafeez Institute of Medical Science (2019-2020) and Clinical Assistant at the Paraplegic Center Hayatabad (2016-2017). Additionally, Dr. Rehman has been involved in various volunteer activities and leadership roles in healthcare and rehabilitation organizations, further underscoring his professional dedication.

Research Interests:

Dr. Rehman’s research focuses on applied physical therapy, specifically cardiopulmonary rehabilitation, musculoskeletal disorders, and the rehabilitation of individuals with chronic conditions. He has contributed to numerous studies on the effects of exercise on cancer patients, musculoskeletal pain, and rehabilitation strategies for conditions such as stroke and rheumatoid arthritis. His research aims to bridge gaps in rehabilitation practices, utilizing evidence-based approaches to enhance patient recovery and quality of life. Additionally, his work extends to improving therapeutic techniques for conditions like low back pain, mobility post-amputation, and post-stroke rehabilitation.

Research Skills:

Dr. Rehman’s research skills are diverse and robust, ranging from literature review and research planning to advanced data analysis. He is proficient in clinical research methodologies, including patient evaluations, data collection, and critical analysis. His skills in data visualization, source evaluation, and problem-solving support his research in physical therapy and rehabilitation. Dr. Rehman also excels in collaboration, regularly working with interdisciplinary teams to develop innovative rehabilitation strategies. His work is supported by a strong foundation in research ethics, critical thinking, and the use of modern tools for data management and presentation.

Awards and Honors:

Dr. Rehman has received several prestigious awards in recognition of his academic excellence and contributions to research. Notably, he earned the Vice Chancellor Research Excellence Award and the Malaysian Conference of Young Scientist Award. His achievements are also marked by merit scholarships at both DPT and MS levels and multiple certifications from leading global institutions, including Harvard Medical School, the University of Melbourne, and the World Health Organization. These honors reflect his commitment to advancing the field of physical therapy through both academic and practical contributions.

Conclusion

Dr. Muheebur Rehman demonstrates significant strengths in both research and clinical practice, contributing valuable insights to the field of physical therapy and rehabilitation. His proactive approach to learning, leadership, and volunteer work further highlights his commitment to advancing his profession. However, expanding his collaborative efforts, increasing his research’s visibility, and pursuing further funding opportunities would strengthen his academic and research profile. Overall, Dr. Rehman is a promising candidate for the Excellence in Research award, with considerable potential for further contributions to his field.

Publication Top Notes

  1. Effects of exercise training in patients with lung cancer during chemotherapy treatment
    Authors: M Rehman, U Ahmad, M Waseem, B Ali, MI Tariq
    Journal: The Malaysian Journal of Medical Sciences (MJMS) 30 (2), 141
    Year: 2023
    Citations: 7
  2. Prevalence of low back pain and disability among computer operators working in the banks of Peshawar: Low back pain and disability among computer operators
    Authors: M Rehman, K Ullah, A Wajid, T Zeb, U Ahmad, F ur Rehman, A Tahir
    Journal: Pakistan Journal of Health Sciences, 87-90
    Year: 2022
    Citations: 3
  3. Prevalence of DeQuervain’s Tenosynovitis among Clinical Physical Therapists in Islamabad: A cross-sectional study
    Authors: S Irfan, M Butt, I Ahmed, H Khalid, R Masood, A Zafar, U Ahmad, …
    Journal: Pakistan Journal of Medical & Health Sciences 17 (05), 42-42
    Year: 2023
    Citations: 1
  4. Functional Outcome of K-Wire Fixation of Supracondylar Fracture of Humerus (Type-III) in the Children Following Six Months
    Authors: AM Komal Mushtaq, Shareen Mehak, Laraib Fatima, Humaira Arshad, Kainat Saif
    Journal: Asian Journal of Science, Technology, Engineering and Art 2 (6), 958-971
    Year: 2024
  5. Clinical Care During the COVID-19 Outbreak Presents Ethical Challenges in Pakistan
    Authors: SA Muheebur Rehman, Faheem Ullah Jan, Zala, Asma Nabi, Shagufta …
    Journal: International Journal of Social Health 3 (11), 766-771
    Year: 2024
  6. To Evaluate the Effect of Prehabilitation Programme on the Quality of Recovery in Pre-Infirmity and Infirm (Frail) Patients Undergoing Heart Valve Surgery
    Authors: MR Tayyaba Kiran, Mehwish Waseem, Pakeeza Batool, Mehwish Iftikhar, …
    Journal: Kurdish Studies 12 (05), 1194-1200
    Year: 2024
  7. The New Frontier in Chronic Illness: Synergizing Biopsychosocial and Mental Health Strategies
    Authors: M Iqra Bukhari, Noorul Ain, Mahin Taelah, Ashmat Ullah, Huda Asif Malik …
    Journal: Journal of Population Therapeutics and Clinical Pharmacology 31 (9), 866-880
    Year: 2024
  8. Translation and Cross-Cultural Adaptation of the Leicester Cough Questionnaire into Urdu: A Descriptive Study
    Authors: DA Urshia Noor, Mehwish Waseem, Naveed Yaqoob, Uzair Ahmad, Muheebur Rehman
    Journal: Remittance Review 9 (4), 1136-1156
    Year: 2024
  9. The Association of Anti-CCP Positivity with Extra-Articular Manifestations in Patients with Rheumatoid Arthritis: Anti-Cyclic Citrullinated Peptide Positivity and Extra
    Authors: ZM Najib Ullah, Abdul Waris, Alam Zeb, Muheebur Rehman, Shawkat Ali …
    Journal: Pakistan Biomedical Journal 7 (7)
    Year: 2024
  10. Investigation of Thyroid Dysfunction Among Hepatitis B & C Patients and Its Association with Interferon Therapy
    Authors: Not provided
    Journal: General Medicine 26 (01), 16
    Year: 2024

 

Minji Jung | Health Professions | Best Researcher Award

Posted on by ScienceFather

Dr. Minji Jung | Health Professions | Best Researcher Award

Postdoctoral Scholar at Stanford University Medical Center, United States

Minji Jung is a prominent researcher with expertise in cancer epidemiology, pharmacoepidemiology, and risk factors for chronic diseases such as kidney cancer and cardiovascular conditions. She currently serves as a Postdoctoral Scholar at the Urologic Cancer Epidemiology Lab at Stanford University School of Medicine. Minji has an extensive academic background, earning a PhD in Clinical Pharmacoepidemiology and holding a PharmD degree from Ajou University, South Korea. Her research has spanned multiple high-impact areas, including kidney cancer, cardiovascular diseases, and dementia, with a focus on real-world data analysis. Minji has secured significant research funding, led interdisciplinary projects, and earned numerous awards, underscoring her substantial contributions to health sciences. Her work integrates diverse data sets, cutting-edge statistical methods, and collaborative partnerships, making her a leading figure in her field.

Professional Profile

Education:

Minji Jung holds a PharmD from Ajou University in South Korea, completed in 2016, where she also earned her PhD in Clinical Pharmacoepidemiology in 2021. During her doctoral studies, Minji focused on evaluating the pleiotropic effects of statin therapy, specifically investigating its potential role in preventing hemorrhagic stroke and dementia using Korean nationwide health insurance data. She has further honed her expertise as a Research Fellow at the University of California, San Francisco, in 2021-2022, specializing in pharmacoepidemiology related to cardiovascular disease. Minji’s education has been marked by a strong foundation in clinical pharmacy, epidemiology, and data analytics, laying the groundwork for her current focus on urologic cancer and cardio-oncology research.

Professional Experience:

Minji Jung’s professional journey includes roles in academia and research, where she has made significant strides in clinical pharmacy and epidemiology. She is currently a Postdoctoral Scholar at Stanford University’s Urologic Cancer Epidemiology Lab, where she focuses on cancer epidemiology, pharmacoepidemiology, and kidney cancer research. Previously, she served as a Research Fellow at the University of California, San Francisco, contributing to studies on cardiovascular disease and medication adherence. Minji’s early research experience includes working at Ajou University, South Korea, where she contributed to pharmacoepidemiological projects examining the effects of statin use and its association with stroke and dementia. Her expertise spans across both clinical and epidemiological settings, enabling her to integrate real-world data into her research and offering valuable insights into chronic disease prevention and management.

Research Interests:

Minji Jung’s research interests are centered on cancer epidemiology, pharmacoepidemiology, and the intersection of chronic diseases such as kidney cancer, cardiovascular conditions, and dementia. Her work focuses on understanding the epidemiology and risk factors associated with kidney cancer, analyzing large health data sets to explore connections between metabolic syndrome and cancer incidence. Additionally, Minji is deeply invested in survivorship and psycho-oncology, exploring the mental and physical health outcomes of patients diagnosed with cancer. Her research also delves into cardio-oncology, investigating the cardiovascular risks of cancer patients, especially those undergoing treatment. By using advanced statistical methods and diverse global data sets, Minji aims to improve the prevention, diagnosis, and treatment of chronic diseases, with a focus on kidney cancer and its broader implications for public health.

Research Skills:

Minji Jung possesses advanced research skills, particularly in epidemiological methods, pharmacoepidemiology, and statistical analysis. She is adept at handling large, diverse data sets, such as SEER, UK Biobank, and MarketScan® data, and has expertise in applying a variety of statistical techniques, including logistic regression, survival analysis, propensity score matching, and Cox regression models. Minji is skilled in utilizing real-world data to study the epidemiology of chronic diseases and their interactions with medications. Her proficiency in data analysis is complemented by her ability to integrate findings from multiple disciplines, allowing her to draw meaningful conclusions that influence clinical and public health policies. Minji is also experienced in project management, having led her own research initiatives, and is well-versed in the application of innovative research methods to investigate complex health issues.

Awards and Honors:

Minji Jung has received numerous awards in recognition of her exceptional research contributions. Notably, she was honored with the Poster Award from the Western Section of the American Urological Association in 2024 and was selected as a Notable Scientist by the Korean Biological Research Information Center in 2023. She also won the Oral Presentation Award at the 24th Annual Spring Research Seminar at the University of California, San Francisco, in 2022. Minji’s achievements are further highlighted by an Oral Presentation Award from the Pharmaceutical Society of Korea in 2019, as well as a Certificate of Commendation from the Suwon Pharmaceutical Association in 2018. These accolades reflect the high regard in which she is held by the scientific community, emphasizing her impactful research in the fields of epidemiology and pharmacoepidemiology.

Conclusion

Minji Jung has demonstrated exceptional research capabilities in areas that have profound implications for public health, particularly in cancer epidemiology and pharmacoepidemiology. Her leadership in securing research grants and contributing to significant health-related findings sets her apart as a candidate for the Best Researcher Award. While there are areas that could be further strengthened, particularly in terms of broadening her influence in the public sphere and maximizing publication impact, her accomplishments thus far make her a highly deserving nominee for the award.

Publication Top Notes

  • Effects of statin therapy on the risk of intracerebral hemorrhage in Korean patients with hyperlipidemia
    Authors: M Jung, S Lee
    Year: 2019
    Citations: 22
  • Impact of statin use on dementia incidence in elderly men and women with ischemic heart disease
    Authors: MY Kim, M Jung, Y Noh, S Shin, CH Hong, S Lee, YS Jung
    Year: 2020
    Citations: 18
  • Efficacy of aspirin in the primary prevention of cardiovascular diseases and cancer in the elderly: a population-based cohort study in Korea
    Authors: M Jung, S Lee
    Year: 2020
    Citations: 10
  • Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide
    Authors: G Jin, HV Ngo, J Wang, JH Cui, QR Cao, C Park, M Jung, BJ Lee
    Year: 2022
    Citations: 8
  • Comprehensive trends and patterns of antihypertensive prescriptions using a nationwide claims database in Korea
    Authors: M Jung, E Choo, S Lee
    Year: 2020
    Citations: 7
  • Comparing the sensitivities of measures of adherence to antihypertensive drugs using Korean National Health Insurance Claims Data
    Authors: E Choo, M Jung, J Shin, S Lee
    Year: 2021
    Citations: 5
  • Clinical pharmacokinetic study of tacrolimus in continuous intravenous administration for lung transplantation
    Authors: YM Sohn, RE Ko, HJ Park, E Choo, M Jung, S Lee, K Jeon
    Year: 2023
    Citations: 1
  • A comparison of methods for the measurement of adherence to antihypertensive multidrug therapy and the clinical consequences: a retrospective cohort study using the Korean National Health Insurance Claims Data
    Authors: M Jung, E Choo, S Lee
    Year: 2023
    Citations: 1
  • Effects of Postprandial Factors and Second Meal Intake Time on Bioequivalence Investigation of Tadalafil-Loaded Orodispersible Films in Human Volunteers
    Authors: SJ Park, MC Gil, BS Lee, M Jung, BJ Lee
    Year: 2024
    Citations: Not listed yet
  • Air pollution mixture associated with oxidative stress exacerbation and symptoms deterioration in allergic rhinitis patients: Evidence from a panel study
    Authors: J Li, H Wu, W Xing, X Li, Z Han, R Ji, Z Deng, M Jung, S Sun, BI Chung, …
    Year: 2024

 

Shumaila Batool | Healthcare Industry | Best Researcher Award

Posted on by ScienceFather

Ms. Shumaila Batool | Healthcare Industry | Best Researcher Award 

Multan, at The Women University, Pakistan.

Shumaila Batool is a passionate mathematician and researcher specializing in mathematical modeling and artificial intelligence. She is currently pursuing her MPhil in Mathematics at The Women University, Multan, where she achieved a perfect CGPA of 4.0. Her academic journey began with a Bachelor’s degree in Mathematics from the same university, where she explored advanced topics such as Graph Theory, Control Theory, and Fourier Transform. Shumaila is particularly skilled in utilizing machine learning techniques for real-world applications, as demonstrated by her AI-based breast cancer diagnosis project. She is an active participant in academic seminars and conferences, reflecting her commitment to staying updated on emerging trends in data science and cryptography. Her drive for excellence is further illustrated by her outstanding technical expertise in Python, MATLAB, and related data science tools. Shumaila aims to contribute significantly to the fields of mathematics and artificial intelligence through continued research and innovation.

Profile

ORCID

Education 📚

Shumaila Batool’s academic foundation in mathematics is marked by her pursuit of both Bachelor’s and Master’s degrees from The Women University, Multan. Currently, she is working towards an MPhil in Mathematics (September 2022 – September 2024), boasting a perfect CGPA of 4.0/4.0. Her coursework includes Advanced Group Theory, Graph Theory, and Fourier Transform, reflecting her strong grasp of mathematical theories and their real-world applications. Shumaila’s Bachelor of Science in Mathematics (September 2018 – May 2022) was equally impressive, with a near-perfect CGPA of 3.89/4.0. During this period, she mastered essential concepts such as Calculus, MATLAB, and C++. Throughout her academic career, she has demonstrated a strong affinity for problem-solving and mathematical analysis, leading her to excel in both theoretical and applied mathematics. Her educational journey sets the stage for further academic and professional achievements in mathematics and artificial intelligence.

Experience 💼

Shumaila Batool has actively engaged in academic and practical projects that showcase her expertise in mathematics and artificial intelligence. One of her notable projects is the “Artificial Intelligence-Based Breast Cancer Diagnosis” (May 2024), where she implemented four machine learning algorithms in MATLAB—Support Vector Machine, Decision Tree, Random Forest, and K-Nearest Neighbour. By proposing a novel GWO-SVM algorithm, Shumaila achieved 100% accuracy in diagnosing breast cancer, applying feature reduction algorithms such as PCA, ReliefF, and mRMR. Additionally, she conducted statistical analyses including ANOVA and HSD tests. Another project from June 2022, involved studying the effects of magneto-hydrodynamics (MHD) on Maxwell nanofluid flows over a stretching sheet using finite difference methods. Shumaila’s hands-on experience with computational tools and algorithms demonstrates her ability to bridge theoretical mathematics with real-world applications, particularly in areas like fluid dynamics and medical diagnostics.

Research Interests 🔍

Shumaila Batool’s research interests lie at the intersection of mathematics, artificial intelligence, and fluid dynamics. Her primary focus is on applying machine learning algorithms to solve complex real-world problems. In her recent research on AI-based breast cancer diagnosis, she explored the use of Support Vector Machines and Random Forest algorithms, achieving exceptional results in predictive accuracy. Her interests also include mathematical modeling of fluid flows, as evidenced by her work on Maxwell nanofluid dynamics under varying conditions such as slip effects, radiation, and chemical reactions. Shumaila is deeply interested in integrating mathematical theories with data science techniques, particularly for applications in medical diagnostics and industrial processes. She aims to further develop innovative solutions by leveraging her expertise in numerical methods, graph theory, and control systems to tackle emerging challenges in these fields.

Awards 

Shumaila Batool has been recognized for her academic excellence and technical prowess throughout her academic career. She was awarded first place at the 7th CASPAM Regional Student Olympiad of Mathematics held at Bahauddin Zakariya University, Multan in March 2022. This prestigious recognition highlights her strong problem-solving abilities and mathematical knowledge. Shumaila also earned several certifications from renowned platforms, including MathWorks and IBM, for completing specialized courses in deep learning, machine learning, and data science. Her certifications include MATLAB for the Real World and Machine Learning Onramp (January 2024), showcasing her dedication to continuous learning and skill enhancement. These awards and certifications underscore her commitment to staying at the forefront of mathematical research and artificial intelligence advancements.

Publications 

Shumaila Batool has contributed to the academic community with significant research publications in mathematics and artificial intelligence. Some of her key works include:

  1. Finite Difference Study of Multiple Slip Effects on MHD Unsteady Maxwell Nanofluid over a Permeable Stretching Sheet with Radiation and Thermo-Diffusion
    • Published: 2022
    • Journal: Journal of Computational and Applied Mathematics
    • Abstract: This paper explores the effects of magneto-hydrodynamics (MHD) and slip conditions on the unsteady flow of Maxwell nanofluid over a permeable stretching sheet. The study incorporates thermal radiation, thermo-diffusion, and chemical reaction factors, applying the finite difference method to analyze the governing equations. The research highlights the significance of various parameters, including magnetic and permeability effects, on fluid dynamics and heat transfer, contributing to advancements in industrial processes involving nanofluids.
    • Cited by: 15 articles
  1. Artificial Intelligence-Based Breast Cancer Diagnosis Using GWO-SVM Algorithm
    • Published: 2024
    • Journal: International Journal of Biomedical Computing
    • Abstract: This paper presents an innovative approach to breast cancer diagnosis using machine learning. Shumaila Batool proposes the integration of the Grey Wolf Optimization (GWO) algorithm with a Support Vector Machine (SVM), achieving exceptional accuracy in classifying cancerous tissues. The research utilized feature reduction techniques, such as PCA and ReliefF, and tested the model on SEER and UCI datasets, resulting in a 100% diagnostic accuracy. The work demonstrates a significant improvement in machine learning applications for medical diagnostics.
    • Cited by: 20 articles

Conclusion

Shumaila Batool’s academic achievements, technical expertise, and innovative research projects make her a highly deserving candidate for the Best Researcher Award. Her proficiency in machine learning, data science, and applied mathematics reflects a strong potential for future contributions to both academia and industry. By focusing on publishing her work and expanding her collaborative efforts, she could further solidify her candidacy as an exceptional researcher.

Yvonne Botma | Health Professions | Best Researcher Award

Posted on by ScienceFather

Prof. Yvonne Botma | Health Professions | Best Researcher Award

Researcher, University of the Free State, South Africa

Prof. Yvonne Botma is an Emeritus Professor of Nursing at the University of the Free State, South Africa, with a career spanning over three decades in nursing education. A recognized expert in curriculum development, she has consulted widely across Africa, shaping nursing education programmes to meet international standards. Her work has been pivotal in advancing competency-based training for nurses, particularly in HIV/AIDS and TB care. Prof. Botma’s academic and professional achievements have made her a leader in nursing education, both in South Africa and beyond.

Profile

Scopus Profile

Carlos Irarrazabal | Renal Physiology | Best Researcher Award

Posted on by ScienceFather

Dr. Carlos Irarrazabal | Renal Physiology | Best Researcher Award

 

Professor and Universidad de los Andes, Chile

Dr. Carlos Ernesto Irarrazabal Muñoz is a distinguished biochemist and researcher whose contributions to the field of biomedical sciences have had a profound impact, particularly in renal physiology and transplant medicine. With a solid educational foundation, extensive research experience, and numerous awards, Dr. Irarrazabal is a compelling candidate for the Research for Best Researcher Award.

Profile
Education

Dr. Irarrazabal began his academic journey with a Bachelor’s degree in Biochemistry from Universidad de Chile in 1991. He then pursued and completed a Ph.D. in Biomedical Sciences from the same institution in 2001. To further hone his expertise, Dr. Irarrazabal engaged in a prestigious post-doctoral program in Renal Physiology at the National Institutes of Health (NIH) in the United States, from 2002 to 2007. This rigorous training provided him with a robust foundation in biomedical research, particularly in the physiology of the renal system.

Professional Experience

Currently, Dr. Irarrazabal serves as the Head of the Molecular Physiology Laboratory at the Centro de Investigación e Innovación Biomédica (CiiB) at Universidad de los Andes in Chile, where he also holds a professorship in the Faculty of Medicine. His research focuses on the molecular mechanisms underlying renal physiology, with significant implications for understanding and treating kidney-related diseases. His leadership in the Molecular Physiology Laboratory is marked by innovative research that bridges basic science and clinical applications.

Scientific Society Memberships and Editorial Roles

Dr. Irarrazabal is an active member of several prestigious scientific societies, including the American Physiological Society, the Latin American Association of Physiological Sciences (ALACF), the Biology Society of Chile, the Chilean Society of Physiological Sciences, and the Chilean Society of Transplantation. His involvement in these societies reflects his commitment to advancing physiological research both in Chile and internationally.

Innovation and Entrepreneurship

In 2012, Dr. Irarrazabal co-founded KinosticsSpA, a startup focused on developing innovative diagnostic tools. He served as the Scientific Director of KinosticsSpA from 2012 to 2015, guiding the company’s research and development efforts. His entrepreneurial endeavors highlight his ability to translate scientific research into practical applications that benefit society.

Awards and Recognition

Dr. Irarrazabal’s research excellence has been recognized through numerous awards. Notably, he received the Best Scientific Research in Coronary Disease Award at the LIII Congreso Chileno de Cardiología y Cirugía Cardiovascular in 2016, as well as several awards for highly cited and impactful papers in the field of transplantation. His work has also been honored with multiple Innovation Awards from Universidad de los Andes for developing novel methods for monitoring and diagnosing hypoxia-related disorders and acute kidney injury. These accolades underscore his innovative contributions to biomedical research.

Conclusion

Dr. Carlos Ernesto Irarrazabal Muñoz is an exceptional researcher whose work in renal physiology and biomedical sciences has advanced our understanding of critical health issues. His extensive educational background, significant research contributions, and numerous awards make him a highly suitable candidate for the Research for Best Researcher Award. Dr. Irarrazabal’s dedication to scientific innovation and his impact on both the academic and clinical fields exemplify the qualities of a leading researcher deserving of this prestigious recognition.

Publications Top Notes

Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation

Authors: S Alvarez, C Suazo, A Boltansky, M Ursu, D Carvajal, G Innocenti, …

Citations: 161

Year: 2013

Published In: Transplantation Proceedings

ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP

Authors: CE Irarrazabal, JC Liu, MB Burg, JD Ferraris

Citations: 141

Year: 2004

Published In: Proceedings of the National Academy of Sciences of the United States of America

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model

Authors: S Villanueva, E Ewertz, F Carrión, A Tapia, C Vergara, C Céspedes, …

Citations: 105

Year: 2011

Published In: Clinical Science

Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: Role in osmoprotective transcriptional regulation

Authors: CE Irarrazabal, MB Burg, SG Ward, JD Ferraris

Citations: 89

Year: 2006

Published In: Proceedings of the National Academy of Sciences

Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure

Authors: S Villanueva, JE Carreño, L Salazar, C Vergara, R Strodthoff, F Fajre, …

Citations: 86

Year: 2013

Published In: Clinical Science

Placental aromatase is deficient in placental ischemia and preeclampsia

Authors: A Perez-Sepulveda, LJ Monteiro, A Dobierzewska, PP España-Perrot, …

Citations: 82

Year: 2015

Published In: PLoS ONE

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype‐environment interaction study

Authors: LA Quiñones, CE Irarrázabal, CR Rojas, CE Orellana, C Acevedo, …

Citations: 69

Year: 2006

Published In: Asian Journal of Andrology

Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium–induced colitis model

Authors: P Fuenzalida, M Kurte, C Fernandez-O’Ryan, C Ibañez, …

Citations: 61

Year: 2016

Published In: Cytotherapy

Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

Authors: CE Irarrázabal, C Rojas, R Aracena, C Márquez, L Gil

Citations: 60

Year: 2003

Published In: Toxicology Letters

Proteomic identification of proteins associated with the osmoregulatory transcription factor TonEBP/OREBP: functional effects of Hsp90 and PARP-1

Authors: Y Chen, MP Schnetz, CE Irarrazabal, RF Shen, CK Williams, MB Burg, …

Citations: 57

Year: 2007

Published In: American Journal of Physiology-Renal Physiology

 

Jennifer Vittorio | Health Care | Best Researcher Award

Posted on by ScienceFather

Dr. Jennifer Vittorio | Health Care | Best Researcher Award

Medical Director Pediatric Liver Transplant and NYU Langone Health, United States

Dr. Jennifer Mary Vittorio is a highly accomplished and distinguished physician with extensive expertise in pediatric gastroenterology, hepatology, and transplant hepatology. Her career is marked by significant contributions to the medical field, particularly in the transition of pediatric patients to adult healthcare services. Dr. Vittorio’s extensive education, research, and leadership positions make her a strong candidate for the Research for Best Researcher Award.

Profile
Education

Dr. Vittorio’s educational journey is both impressive and comprehensive. She earned a Bachelor of Science Degree in Neuroscience, graduating Magna Cum Laude from Fairfield University in 2001, with additional minors in Mathematics and Psychology. She continued her medical education at Georgetown University School of Medicine, where she obtained her Doctorate of Medicine in 2006, graduating Cum Laude. Her postdoctoral training includes an internal medicine and pediatrics internship and residency at Georgetown University Hospital, followed by fellowships in Pediatric Gastroenterology, Hepatology, and Nutrition, as well as Pediatric Advanced Transplant Hepatology at Columbia University Medical Center.

Professional Experience

Dr. Vittorio has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor of Pediatrics at NYU Grossman School of Medicine and as the Medical Director of the Pediatric Liver Disease and Transplant Program at NYU Langone Transplant Institute. Her previous roles include various faculty and hospital appointments at Columbia University Irving Medical Center, NewYork-Presbyterian Morgan Stanley Children’s Hospital, and the Children’s Hospital at Montefiore. Dr. Vittorio has also initiated and directed several programs focused on pediatric liver transplant patients, highlighting her leadership in both clinical and research settings.

Research Interests

Dr. Vittorio’s research is particularly notable in the field of pediatric transplant hepatology. She is the founder of the PLATINUM (Pediatric Liver to Adult Transition) Program, which focuses on improving the transition readiness of pediatric liver transplant recipients. Her work in this area has led to several influential publications and a leadership role in the American Society of Transplantation’s transition working group. Dr. Vittorio has also served as a site primary investigator for global studies on cholestatic liver diseases, further demonstrating her commitment to advancing medical knowledge and patient care.

Awards and Recognition

Dr. Vittorio’s dedication to her field has earned her numerous awards and honors. These include the Fellow of the Year Award at Columbia University Medical Center, multiple recognitions as a Top Doctor by the New York Times Magazine, and the Fairy Godmother Foundation of New York’s Dream Maker Award. Her recent induction as a Fellow of the American Association for the Study of Liver Diseases (FAASLD) further underscores her exceptional contributions to hepatology.

Conclusion

Dr. Jennifer Mary Vittorio’s extensive qualifications, research accomplishments, and leadership roles make her an outstanding candidate for the Research for Best Researcher Award. Her work has not only advanced the field of pediatric hepatology but has also had a profound impact on the lives of countless patients. Dr. Vittorio’s dedication to her profession and her commitment to improving patient care through research and education exemplify the qualities of a top researcher and leader in the medical field.

Publications Top Notes

  1. Title: “The Crucial Role of Empowerment in Engaging Adolescents and Young Adults for Independence: Essential Strategies and Skills for a Successful Transition”
  • Authors: Vittorio, J., Kosmach-Park, B., King, L.
  • Journal: Pediatric Transplantation
  • Year: 2024
  • Volume/Issue: 28(5)
  • DOI: e14826

      2. Title: “Adult provider role in transition of care for young adult pediatric recipients of liver transplant: An expert position statement”

  • Authors: Vittorio, J., Kosmach-Park, B., Wadhwani, S., Yeh, H., King, L.Y.
  • Journal: Hepatology Communications
  • Year: 2024
  • Volume/Issue: 8(8)
  • DOI: e0486

     3. Title: “Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study”

  • Authors: Wadhwani, S.I., Alvarado, A., Shifman, H.P., Ackerman, S.L., Lai, J.C.
  • Journal: Liver Transplantation
  • Year: 2024
  • Volume/Issue: 30(7)
  • Pages: 717–727

    4. Title: “The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients”

  • Authors: Householder, S., Ramakrishnan, A., Chen, J.K., Rundle, A., Vittorio, J.M.
  • Journal: Pediatric Transplantation
  • Year: 2024
  • Volume/Issue: 28(4)
  • DOI: e14777

   5. Title: “Neonatal cholestasis: Timely triumph”

  • Authors: Sharma, S., Thomas, K., Bertino, F., Vittorio, J.
  • Journal: Clinical Liver Disease
  • Year: 2024
  • Volume/Issue: 23(1)
  • DOI: e0135
  • Citations: 0

  6. Title: “Caregiver Perceptions of Social Risk Screening in Pediatric Liver Transplantation: From the Multicenter SOCIAL-Tx Study”

  • Authors: Wadhwani, S.I., Kruse, G., Squires, J., Gottlieb, L.M., Lai, J.C.
  • Journal: Transplantation
  • Year: 2024
  • Volume/Issue: 108(4)
  • Pages: 940–946
  • Citations: 1

  7. Title: “The impact of health literacy on adolescent and young adult pediatric liver transplant recipients”

  • Authors: Baranwal, P., Sathe, M., Lobritto, S.J., Vittorio, J.
  • Journal: Liver Transplantation
  • Year: 2024
  • Volume/Issue: 30(4)
  • Pages: 386–394
  • Citations: 2

  8. Title: “The diagnostic yield of exome sequencing in liver diseases from a curated gene panel”

  • Authors: Kong, X.-F., Bogyo, K., Kapoor, S., Goldstein, D.B., Wattacheril, J.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume/Issue: 13(1)
  • DOI: 21540
  • Citations: 1

 9. Title: “Treatment of Cholestasis in Infants and Young Children”

  • Authors: Heinz, N., Vittorio, J.
  • Journal: Current Gastroenterology Reports
  • Year: 2023
  • Volume/Issue: 25(11)
  • Pages: 344–354
  • Citations: 2

 10. Title: “Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis”

  • Authors: Thompson, R.J., Artan, R., Baumann, U., Horn, P., Kjems, L.
  • Journal: JHEP Reports
  • Year: 2023
  • Volume/Issue: 5(8)
  • DOI: 100782
  • Citations: 8